Reaktion #53716
ord-08c484b14397498d852877d4b932426c
Reaktionsgleichung
Edukte
Reagenzien
Lösungsmittel
Reaktionsbedingungen
Aufarbeitung
- 1Sonstigethe compound is prepared
- 2SonstigeEach reaction is prepared
- 3SonstigeThe tube is sealed with the stopper
- 4Sonstigeprovided for this purpose
- 5Sonstigefor 5 minutes
- 6Sonstigeat 120° C
- 7FiltrationThe catalyst is filtered through Celite® 535
- 8Sonstigethe four reaction crudes
- 9Einengenconcentrated to dryness under reduced pressure in the rotary evaporator
- 10Sonstigepurified by preparative LC/MS (conditions A)
- 11workup.ADDITIONThe fractions containing the protected intermediate compound
- 12Einengenconcentrated under reduced pressure
- 13SonstigeThe yellow oil obtained
- 14Trocknenthe organic phase is dried over magnesium sulfate
- 15Einengenthe solvent is concentrated to dryness under reduced pressure
- 16Sonstigea rotary evaporator
Vorschrift
2-Methylsulfonyl-N-(3-phenylamino-1H-indazol-5-yl)benzenesulfonamide can be obtained in the following way: the compound is prepared by reacting under microwave radiation on a Personal Chemistry Emrys Optimizer device. Four identical reactions are carried out. Each reaction is prepared as follows: 60 mg of tert-butyl 3-iodo-5-(N-tert-butoxycarbonyl-2-methylsulfonylbenzenesulfonylamino)indazole-1-carboxylate are placed in a Personal Chemistry SmithProcessVial™ tube with a maximum volume of 5 ml. 404 mg of cesium carbonate, 35.9 mg of 2-dicyclohexylphosphino-2′-(N,N-dimethylamino)biphenyl, 12.1 mg of tris(dibenzylideneacetone)dipalladium[0] and 29 μl of aniline are then added. 4 ml of 1,2-dimethoxyethane are then added. The tube is sealed with the stopper provided for this purpose and the reaction is subjected to microwave radiation for 5 minutes at 120° C. The other parameters are those recommended by the constructor. The catalyst is filtered through Celite® 535 and the four reaction crudes are pooled, concentrated to dryness under reduced pressure in the rotary evaporator and purified by preparative LC/MS (conditions A). The fractions containing the protected intermediate compound are pooled and concentrated under reduced pressure. The yellow oil obtained is dissolved in 2 ml of dichloromethane and then 500 μl of trifluoroacetic acid are added. The solution is stirred for 2 hours at ambient temperature, until the starting product has disappeared. 10 ml of dichloromethane and 10 ml of a saturated sodium hydrogencarbonate solution are then added. When no more gas is being given off, the organic phase is dried over magnesium sulfate and the solvent is concentrated to dryness under reduced pressure and a rotary evaporator. 18.6 mg of 2-methylsulfonyl-N-(3-phenylamino-1H-indazol-5-yl)benzenesulfonamide are obtained in the form of a yellow oil (analytical LC/MS analysis: Tr=3.49 minutes; [M+H]+=443.09).